Zimmer Biomet Holdings Noncontrolling interests in subsidiaries increased by 1.2% to $8.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.7%, from $8.70M to $8.20M. Over 5 years (FY 2020 to FY 2025), Noncontrolling interests in subsidiaries shows an upward trend with a 9.3% CAGR.
Changes reflect the acquisition or divestiture of minority stakes in subsidiaries or the relative profitability of those specific entities.
This represents the portion of equity in a subsidiary that is not attributable, directly or indirectly, to the parent co...
Common in companies with complex organizational structures and joint ventures.
other_minority_interest| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.40M | $5.60M | $5.70M | $5.90M | $6.20M | $6.40M | $6.70M | $6.90M | $7.10M | $7.20M | $7.70M | $8.10M | $8.40M | $8.50M | $8.10M | $8.70M | $9.30M | $9.50M | $8.10M | $8.20M |
| QoQ Change | — | +3.7% | +1.8% | +3.5% | +5.1% | +3.2% | +4.7% | +3.0% | +2.9% | +1.4% | +6.9% | +5.2% | +3.7% | +1.2% | -4.7% | +7.4% | +6.9% | +2.2% | -14.7% | +1.2% |
| YoY Change | — | — | — | — | +14.8% | +14.3% | +17.5% | +16.9% | +14.5% | +12.5% | +14.9% | +17.4% | +18.3% | +18.1% | +5.2% | +7.4% | +10.7% | +11.8% | +0.0% | -5.7% |